Differential sensitivity of human islets from obese versus lean donors to chronic high glucose or palmitate

Details

Serval ID
serval:BIB_0F8F92DBC03A
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Differential sensitivity of human islets from obese versus lean donors to chronic high glucose or palmitate
Journal
J Diabetes
Author(s)
Castex F., Leroy J., Broca C., Mezghenna K., Duranton F., Lavallard V., Lebreton F., Gross R., Wojtusciszyn A., Lajoix A. D.
ISSN
1753-0407 (Electronic)
ISSN-L
1753-0407
Publication state
Published
Issued date
07/2020
Volume
12
Number
7
Pages
532-541
Language
english
Notes
Castex, Francoise
Leroy, Jeremy
Broca, Christophe
Mezghenna, Karima
Duranton, Flore
Lavallard, Vanessa
Lebreton, Fanny
Gross, Rene
Wojtusciszyn, Anne
Lajoix, Anne-Dominique
eng
Centre Hospitalier Regional Universitaire de Montpellier
BQR 2011/University Montpellier
AOI-2010/UF8687/Montpellier University Hospital
3-RSC-2016-162-I-X/JDRF/Juvenile Diabetes Research Foundation/
Australia
J Diabetes. 2020 Jul;12(7):532-541. doi: 10.1111/1753-0407.13026. Epub 2020 Mar 6.
Abstract
BACKGROUND: Due to the shortage of multi-organ donors, human pancreatic islet transplantation has now been extended to islets originating from obese subjects. In this study, our aim is to compare the respective sensitivity of human islets from lean vs obese donors to chronic high glucose or high palmitate. METHODS: Human islets were isolated from pancreases harvested from brain-dead multi-organ donors. Islets were cultured during 72 hours in the presence of moderate (16.7 mmol/L) or high (28 mmoL/L) glucose concentrations, or glucose (5.6 mmoL/L) and palmitate (0.4 mmoL/L), before measurement of their response to glucose. RESULTS: We first observed a greater insulin response in islets from obese donors under both basal and high-glucose conditions, confirming their hyperresponsiveness to glucose. When islets from obese donors were cultured in the presence of moderate or high glucose concentrations, insulin response to glucose remained unchanged or was slightly reduced, as opposed to that observed in lean subjects. Moreover, culturing islets from obese donors with high palmitate also induced less reduction in insulin response to glucose than in lean subjects. This partial protection of obese islets is associated with less induction of inducible nitric oxide synthase in islets, together with a greater expression of the transcription factor forkhead box O1 (FOXO1). CONCLUSIONS: Our data suggest that in addition to an increased sensitivity to glucose, islets from obese subjects can be considered as more resistant to glucose and fatty acid excursions and are thus valuable candidates for transplantation.
Keywords
Aged, Glucose/*pharmacology, Humans, Insulin Secretion/*drug effects, Islets of Langerhans/*drug effects/metabolism, Male, Middle Aged, Obesity/*metabolism, Palmitates/*pharmacology, human islets, insulin secretion, islet transplantation, nitric oxide synthase, obesity
Pubmed
Create date
14/06/2021 9:58
Last modification date
15/06/2021 6:36
Usage data